LACTOSE (INDIA)
|
The Current P/E Ratio of LACTOSE (INDIA) is 21.42.
| Share Price | ₹103.1 | Jul 07,2026 |
| Market Cap | ₹129.8 Cr | |
| Earnings-TTM | ₹6.1 Cr | TTM-Standalone Results |
| Price/Earnings | 21.42x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of LACTOSE (INDIA)
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹129.8 Cr] as on Jul 07,2026
(/) Earnings [ ₹6.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 21.42x ]
Thus, for LACTOSE (INDIA) , the investors are currently willing to pay 21.42 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LACTOSE (INDIA) !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LACTOSE (INDIA) over the last five years.
Historical PE (Price/Earnings) ratio chart of LACTOSE (INDIA)
PE Ratio Performance Analysis for LACTOSE (INDIA)
- LACTOSE (INDIA) 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.82x.
- LACTOSE (INDIA) 's operated at median p/e ratio of 25.87x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LACTOSE (INDIA) 's p/e ratio peaked in Mar2023 at 45.81x.
- LACTOSE (INDIA) 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does LACTOSE (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| LACTOSE (INDIA) | 6.06 | 21.42 | 129.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 39.48 | 456,593.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 69.99 | 179,737.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 76.84 | 164,290.0 |
| CIPLA LTD | 3,869.79 | 30.32 | 117,327.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 27.27 | 112,994.0 |
| MANKIND PHARMA LTD | 1,926.41 | 54.27 | 104,550.0 |
| LUPIN LTD | 5,355.47 | 21.26 | 113,844.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.88 | 115,002.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 26.01 | 91,082.3 |
| LAURUS LABS LTD | 889.85 | 89.66 | 79,784.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LACTOSE (INDIA) 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 21.26x |
| Max industry PE | 89.66x |
| Median industry PE | 30.32x |
| Average industry PE | 43.58x |
You may also like the below Video Courses